{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:28:53Z","timestamp":1769221733361,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005247","name":"University of British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.humpath.2020.04.005","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T11:33:07Z","timestamp":1587555187000},"page":"10-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Claudin-4 shows superior specificity for mesothelioma vs non\u2013small-cell lung carcinoma compared with MOC-31 and Ber-EP4"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7799-7860","authenticated-orcid":false,"given":"Julia R.","family":"Naso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Churg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2020.04.005_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the international mesothelioma interest group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2020.04.005_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.15698\/cst2019.06.188","article-title":"Biology and clinical relevance of EpCAM","volume":"3","author":"Keller","year":"2019","journal-title":"Cell Stress"},{"key":"10.1016\/j.humpath.2020.04.005_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/modpathol.3800544","article-title":"The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study","volume":"19","author":"Ord\u00f3\u00f1ez","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.04.005_bib4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1309\/AJCP0B3YJBXWXJII","article-title":"Value of claudin-4 immunostaining in the diagnosis of mesothelioma","volume":"139","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2020.04.005_bib5","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/modpathol.2013.34","article-title":"Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma","volume":"26","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.04.005_bib6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/modpathol.2012.200","article-title":"Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas","volume":"26","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.04.005_bib7","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/cyt.12765","article-title":"Claudin-4 immunohistochemistry is a useful pan-carcinoma marker for serous effusion specimens","volume":"30","author":"Vojtek","year":"2019","journal-title":"Cytopathology"},{"key":"10.1016\/j.humpath.2020.04.005_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/cncy.21392","article-title":"Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology","volume":"122","author":"Jo","year":"2014","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.humpath.2020.04.005_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/dc.23476","article-title":"Immunocytochemical utility of claudin-4 versus those of Ber-EP4 and MOC-31 in effusion cytology","volume":"44","author":"Oda","year":"2016","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.humpath.2020.04.005_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ijc.2910580315","article-title":"Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells","volume":"58","author":"Veatch","year":"1994","journal-title":"Int J Canc"},{"key":"10.1016\/j.humpath.2020.04.005_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/his.13073","article-title":"Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma","volume":"70","author":"Kushitani","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2020.04.005_bib12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00428-007-0448-x","article-title":"Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions","volume":"451","author":"Facchetti","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2020.04.005_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/dc.21380","article-title":"Usefulness of Claudin 4 in the cytological diagnosis of serosal effusions","volume":"39","author":"Lonardi","year":"2011","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.humpath.2020.04.005_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2012.05.014","article-title":"Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update","volume":"44","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.04.005_bib15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/jcp.2005.028589","article-title":"Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura","volume":"59","author":"Soini","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2020.04.005_bib16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.humpath.2017.07.015","article-title":"The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell\/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center","volume":"67","author":"Marchevsky","year":"2017","journal-title":"Hum Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720300770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720300770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:36:27Z","timestamp":1758645387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817720300770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":16,"alternative-id":["S0046817720300770"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2020.04.005","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Claudin-4 shows superior specificity for mesothelioma vs non\u2013small-cell lung carcinoma compared with MOC-31 and Ber-EP4","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2020.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}